Literature DB >> 17468459

Short-term intravenous iloprost for treatment of reperfusion lung oedema after pulmonary thromboendarterectomy.

Hsao-Hsun Hsu1, Jin-Shing Chen, Yih-Sharng Chen, Wen-Je Ko, Shuenn-Wen Kuo, Yung-Chie Lee.   

Abstract

This case report describes the treatment of reperfusion lung oedema after pulmonary thromboendarterectomy using intravenous iloprost infusion in a 52-year-old woman diagnosed with chronic thromboembolic pulmonary hypertension.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17468459      PMCID： PMC2117199          DOI： 10.1136/thx.2005.051722

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  9 in total

Review 1.  Surgery for chronic thromboembolic pulmonary hypertension.

Authors:  R S Hartz
Journal:  World J Surg       Date:  1999-11       Impact factor: 3.352

2.  Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism.

Authors:  H Imanaka; H Miyano; M Takeuchi; K Kumon; M Ando
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

3.  Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

Authors:  C F Opitz; R Wensel; M Bettmann; R Schaffarczyk; M Linscheid; R Hetzer; R Ewert
Journal:  Eur Heart J       Date:  2003-02       Impact factor: 29.983

4.  Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy.

Authors:  R M Levinson; D Shure; K M Moser
Journal:  Am Rev Respir Dis       Date:  1986-12

5.  Current early results of pulmonary thromboendarterectomy for chronic pulmonary embolism.

Authors:  P O Daily; W P Dembitzsky; S Iversen; K M Moser; W Auger
Journal:  Eur J Cardiothorac Surg       Date:  1990       Impact factor: 4.191

6.  Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy.

Authors:  Thorsten Kramm; Balthasar Eberle; Frank Krummenauer; Stefan Guth; Hellmut Oelert; Eckhard Mayer
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

7.  Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

Authors:  O Sitbon; F Brenot; A Denjean; A Bergeron; F Parent; R Azarian; P Herve; B Raffestin; G Simonneau
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

8.  Pulmonary endarterectomy: experience and lessons learned in 1,500 cases.

Authors:  Stuart W Jamieson; David P Kapelanski; Naohide Sakakibara; Gerard R Manecke; Patricia A Thistlethwaite; Kim M Kerr; Richard N Channick; Peter F Fedullo; William R Auger
Journal:  Ann Thorac Surg       Date:  2003-11       Impact factor: 4.330

9.  Inhaled iloprost for severe pulmonary hypertension.

Authors:  Horst Olschewski; Gerald Simonneau; Nazzareno Galiè; Timothy Higenbottam; Robert Naeije; Lewis J Rubin; Sylvia Nikkho; Rudolf Speich; Marius M Hoeper; Jürgen Behr; Jörg Winkler; Olivier Sitbon; Wladimir Popov; H Ardeschir Ghofrani; Alessandra Manes; David G Kiely; Ralph Ewert; Andreas Meyer; Paul A Corris; Marion Delcroix; Miguel Gomez-Sanchez; Harald Siedentop; Werner Seeger
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.